Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc. (Nasdaq: NAUT) is a life sciences company that entered the public markets through a merger with Arya Sciences Acquisition Corp III, a blank-check company sponsored by Arya Sciences — the SPAC vehicle affiliated with healthcare-focused investment firm Perceptive Advisors. Arya Sciences Acquisition Corp III completed its IPO in 2020, filing a 424B4 prospectus with the SEC in August of that year. The SPAC targeted the biotechnology and life sciences sector. Post-combination, Nautilus Biotechnology operates as a publicly traded proteomics company focused on single-molecule protein analysis technology. Visit SpacDesk and sign up for full data, deal timelines, and filing history on this and every active SPAC transaction.